Ironwood pharmaceuticals news
WebApr 15, 2024 · The stock, however, is off -83.80% from where it was a year ago. Additionally, there is a loss of -2.06% for Cumberland Pharmaceuticals Inc. (CPIX) in last trading while the stock has seen an overall depriciation of -26.73%% over the past year. The PE ratio stands at 11.39 for Ironwood Pharmaceuticals Inc., compared to 70.08 for AstraZeneca PLC. WebMar 2, 2024 · Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD) Shares Could Be 40% Below Their Intrinsic Value Estimate Simply Wall St March 2, 2024, 7:09 AM · 6 min read Key Insights The projected fair value...
Ironwood pharmaceuticals news
Did you know?
WebApr 11, 2024 · On April 10, 2024, Ironwood Pharmaceuticals, Inc. determined to eliminate the role of chief operating officer to streamline the executive leadership team. Accordingly, Jason Rickard's last day as Senior Vice President, Chief Operating Officer, and as an employee of the Company, will be May 12, 2024. WebIronwood Pharmaceuticals Non-GAAP EPS of $0.28 beats by $0.01, revenue of $108.64M misses by $1.76M, reaffirms FY guidance. Markets Insider Automation 54d. Ironwood Pharmaceuticals A earnings ...
WebApr 11, 2024 · Ironwood Pharmaceuticals ( NASDAQ: IRWD) said on Tuesday that COO Jason Rickard's last day in the company will be May 12. The company is set to eliminate the role of COO, and Rickard's ... WebIronwood Pharmaceuticals is a leading gastrointestinal (GI) healthcare company on a mission to advance the treatment of GI diseases and redefine the standard of care for GI …
WebApr 11, 2024 · Ironwood Pharmaceuticals ( NASDAQ: IRWD) said on Tuesday that COO Jason Rickard's last day in the company will be May 12. The company is set to eliminate … WebSep 6, 2024 · BOSTON, Mass., September 06, 2024--Ironwood Pharmaceuticals, Inc. (Nasdaq: IRWD), today announced positive topline data from a Phase III clinical trial …
WebApr 10, 2024 · Ironwood Pharmaceuticals, Inc. is a healthcare company, which engages in the development and commercialization of Gastrointestinal (GI) products. It operates through the Human Therapeutics...
WebApr 10, 2024 · Ironwood Pharmaceuticals has a news sentiment score of -0.53. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.41 average news sentiment score of Medical companies. crystal palace starting 11 todayWeb1 hour ago · The counties faced "severe conditions and sustained serious damage caused by widespread flooding," according to a news release sent by the governor's office Friday. … dy/dx sin x y differential equationWeb2 days ago · Ironwood Pharmaceuticals IRWD rose 3.4% amid speculation about an activist investor in the gastro intestinal drug company.; Gordon Haskett in a note on Thursday … dydx united statesWebApr 14, 2024 · In other Ironwood Pharmaceuticals news, COO Jason Rickard sold 16,746 shares of the stock in a transaction on Monday, February 27th. The shares were sold at an average price of $11.41, for a total ... dydy\u0027s kitchenWeb1 day ago · BOSTON-- (BUSINESS WIRE)--Ironwood Pharmaceuticals, Inc. (Nasdaq: IRWD), a GI-focused healthcare company, today reported its second quarter 2024 results and recent business performance. “We made progre... 8 months ago - Business Wire Ironwood Pharmaceuticals to Host Second Quarter 2024 Investor Update Call dy/dx of cscxWebIt is hard to get excited after looking at Ironwood Pharmaceuticals' (NASDAQ:IRWD) recent performance, when its stock... Zacks Strength Seen in Xencor (XNCR): Can Its 5.3% Jump … dye4changeWebGreat news for Ford and Canadian Automotive industry! ... Director at Ironwood Pharmaceuticals Greater Boston. Lara Lane Nursing Student seeking RN Position Tampa, … crystal palace stadium parking